Report Categories
View AllRecent Articles
View All
PLX Q1 2026 Earnings Massive EPS Surprise as Protalix BioTherapeutics Reports Strong Profitability
PAPL Q3 2025 Earnings NarrowerthanExpected Loss Boosts Sentiment Despite Negative Market Reaction
IMMR Q3 2025 Earnings EPS Beat Drives Positive Market Reaction Licensing Revenue Remains Opaque
DJCO Q4 2025 Earnings Strong EPS of 3061 Highlights Profitability Amidst No Revenue Disclosure
WTW Q1 2026 Earnings Adjusted EPS Slightly Beats Estimates Shares Edge Lower